SBC Medical Group Holdings Incorporated (SBC)

SBC Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for SBC stock has a target of 8.00, which predicts a 135.29% increase from the current stock price of 3.4.

Price Target: $8.00 (+135.29%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$8.00	$8.00	$8.00	$8.00
Change	+135.29%	+135.29%	+135.29%	+135.29%

* Price targets were last updated on Mar 6, 2026.

Analyst Ratings

According to 1 stock analyst, the rating for SBC is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Mar '26	Apr '26
Strong Buy	1	1
Buy	0	0
Hold	0	0
Sell	0	0
Strong Sell	0	0
Total	1	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Sam Eiber BTIG	BTIG	Strong Buy Initiates $8	Strong Buy	Initiates	$8	+135.29%	Mar 6, 2026

Financial Forecast

Revenue This Year

181.17M

Increased by 4.36%

from 173.61M

Revenue Next Year

196.89M

Increased by 8.68%

from 181.17M

EPS This Year

0.44

Decreased by -10.90%

from 0.50

EPS Next Year

0.49

Increased by 12.21%

from 0.44

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028
Period Ending	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027	Dec 31, 2028
Revenue	174.16M	193.54M	205.42M	173.61M	181.17M	196.89M	201.09M
Revenue Growth	-	11.13%	6.14%	-15.49%	4.36%	8.68%	2.13%
EPS	0.79	0.42	0.48	0.50	0.44	0.49	0.51
EPS Growth	-	-47.39%	15.50%	2.54%	-10.90%	12.21%	2.04%
Forward PE	-	-	-	-	7.71	6.87	6.73
No. Analysts	-	-	-	-	5	4	2

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028
High	191.2M	210.3M
Avg	181.2M	196.9M
Low	170.4M	182.3M

Revenue Growth

Revenue Growth	2026	2027	2028
High	10.1%	16.1%
Avg	4.4%	8.7%
Low	-1.8%	0.6%

EPS Forecast

EPS	2026	2027	2028
High	0.49	0.55
Avg	0.44	0.49
Low	0.39	0.46

EPS Growth

EPS Growth	2026	2027	2028
High	-0.3%	23.8%
Avg	-10.9%	12.2%
Low	-20.8%	4.4%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.